Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 12090151 Injectable sustained release buprenorphine formulation

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Date Filed
May 12, 2023
0
Date of Patent
September 17, 2024
0
Patent Application Number
18316911
0
Patent Citations
‌
US Patent 9480276 Dry food product containing live probiotic
0
‌
US Patent 10555899 Long-acting non-aqueous injectable formulations and use thereof
0
‌
US Patent 7820145 Oleaginous pharmaceutical and cosmetic foam
0
‌
US Patent 8093261 Rapid release mini-tablets provide analgesia in laboratory animals
0
‌
US Patent 8518378 Oleaginous pharmaceutical and cosmetic foam
0
‌
US Patent 9333180 Nanocapsules with a liquid lipid core charged with water-soluble or water-dispersible active agents
0
‌
US Patent 9333181 Method for preparing functionalized lipid capsules
0
Patent Inventor Names
Michael Guarnieri
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
12090151
0
Patent Primary Examiner
‌
Jean P Cornet
0
CPC Code
‌
A61K 31/485
0
‌
A61K 9/0019
0
‌
A61K 47/14
0

Find more entities like US Patent 12090151 Injectable sustained release buprenorphine formulation

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.